Recent studies of currently available oral contraceptives indicate that the risk of major
sequelae is low in young women (aged between 20 and 24 years). Venous …

We present a case of a 27-year-old women admitted to the hospital with migraine and left
upper extremity weakness. Subsequent imaging with computed tomography and magnetic …

We determined the influence of oral contraceptives (OC) on the capacity of the endothelium
to release tissue-type plasminogen activator (t-PA). Twenty-three healthy premenopausal …

Ischemic colitis is generally considered a disease of the elderly. The causes of ischemic
colitis include low-flow states due to cardiac dysfunction or hypovolemia and certain …

OBJECTIVES: To comparatively evaluate the impact of a balanced one-third dose-reduced
oral contraceptive on hemostatic variables. METHODS: In an open-label, randomized study …

Abstract Case Description—A 7-month-old 16.6-kg (36.5-lb) sexually intact female Golden
Retriever was evaluated because of progressive severe bilateral membranous conjunctivitis …

The use of oral contraceptives (OCs) is known to increase the risk of thrombosis, but the
mechanisms underlying this risk and the determinants of the tests that assess this risk are …

The use of oral contraceptives (OC) is associated with an increased risk of thrombosis,
suggesting OC exert procoagulant and/or antifibrinolytic effects. Given that physical exercise …

Thrombin activatable fibrinolysis inhibitor (TAFI) is a zymogene that potently inhibits
fibrinolysis through the removal of the carboxy-terminal lysine and arginine residues from …

Venous thromboembolic diseases are the major concern of rising cost of healthcare and are
commonest health problem across the globe. Both genetic and acquired risk factors are …